BioMarin Pharmaceutical Inc. (BMRN) Financials

BMRN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 8.6 billion 2.4 billion
Dec. 31, 2025 7.6 billion 1.5 billion
Sept. 30, 2025 7.6 billion 1.6 billion
June 30, 2025 7.5 billion 1.4 billion

BMRN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 199.7 million 43.5 million
Dec. 31, 2025 58.9 million 46.9 million
Sept. 30, 2025 340.2 million 49.3 million
June 30, 2025 168.2 million 47.5 million

BMRN Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 105.5 million
Dec. 31, 2025 139.1 million
Sept. 30, 2025 -30.7 million
June 30, 2025 426.2 million

BMRN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 2.2 billion 1.4 billion 9.3 million
Dec. 31, 2025 1.6 billion 597.2 million 37.0 million
Sept. 30, 2025 1.5 billion 596.7 million 7.6 million
June 30, 2025 1.4 billion 596.2 million 7.7 million

BMRN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 197.7 million
Dec. 31, 2025 197.4 million
Sept. 30, 2025 192.0 million
June 30, 2025 196.6 million

BMRN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 20.9 million 178.8 million 258.3 million 124.9 million
Dec. 31, 2025 40.7 million 192.4 million 802.1 million -
Sept. 30, 2025 28.4 million 409.5 million 268.4 million 131.3 million
June 30, 2025 17.1 million 161.3 million 232.3 million 122.1 million

BMRN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 766.2 million 195.0 million
Dec. 31, 2025 874.6 million 295.1 million
Sept. 30, 2025 776.1 million 140.1 million
June 30, 2025 825.4 million 150.1 million

BMRN Revenue by Segment
Graph available only for paid members. Upgrade to see it.

BMRN

Price: $55.26

52 week price:
49.26
66.28

Earnings Per Share: 1.39 USD

P/E Ratio: 38.89

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.1 million

Ebitda: 11.0 million

Market Capitalization: 10.9 billion

Links: